Date	Headline/Title
05-04-2024	Change to the board of directors of Remgro
05-04-2024	Dealings in securities by an independent non-executive director
27-03-2024	Dealings in securities by an executive director and prescribed officer
19-03-2024	Summary of unaudited results for the six months ended 31 December 2023 and cash dividend declaration
15-03-2024	Summary of Mediclinic results for the six months ended 30 Sept 2023 and outlook for the year ending 31 Mar 2024
11-03-2024	Trading statement for the six months ended 31 December 2023